Enzo Biochem, Inc. (NYSE:ENZ – Get Free Report) announced a dividend on Tuesday, October 29th, NASDAQ reports. Stockholders of record on Friday, November 15th will be given a dividend of 0.10 per share by the medical research company on Monday, December 2nd. The ex-dividend date of this dividend is Friday, November 15th.
Enzo Biochem Stock Performance
Enzo Biochem stock traded up $0.03 during mid-day trading on Wednesday, reaching $1.16. The stock had a trading volume of 331,081 shares, compared to its average volume of 95,885. Enzo Biochem has a one year low of $0.99 and a one year high of $1.50. The company has a 50-day moving average price of $1.13 and a two-hundred day moving average price of $1.11.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Enzo Biochem in a research report on Wednesday. They issued a “hold” rating on the stock.
Enzo Biochem Company Profile
Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.
Read More
- Five stocks we like better than Enzo Biochem
- What to Know About Investing in Penny Stocks
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Canadian Penny Stocks: Can They Make You Rich?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Calculate Stock Profit
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
